BioPlus Acquisition Corp.
BIOSDelisted Oct 6, 2023- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001856653
BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding BioPlus Acquisition Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 67 | 66 | −1 |
| Shares | 20.1M | 20.8M | +711.9K (+3.5%) |
| Value | $201.7M | $213.3M | +$11.6M (+5.7%) |
New holders (7)
Institutions that held BioPlus Acquisition Corp. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Calamos Advisors LLC | 1,000,000 | $10.3M | 0.05% |
| LMR Partners LLP | 250,000 | $2.56M | 0.06% |
| Westchester Capital Management, LLC | 164,243 | $1.69M | 0.05% |
| Exos TFP Holdings LLC | 62,500 | $638.8K | 0.18% |
| Weiss Asset Management LP | 52,389 | $538.6K | 0.03% |
| Virtu Financial LLC | 11,401 | $117.0K | 0.02% |
| Tower Research Capital LLC (TRC) | 92 | $1.00K | 0.00% |
Sold out (8)
Institutions that held BioPlus Acquisition Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Oconnor LLC | 467,907 | $4.70M |
| Citigroup Inc | 394,980 | $3.96M |
| Parallax Volatility Advisers, L.P. | 221,829 | $2.23M |
| Context Capital Management, LLC | 110,068 | $1.11M |
| JPMorgan Chase & Co | 103,674 | $1.04M |
| Wealthspring Capital LLC | 39,450 | $395.0K |
| Clear Street LLC | 1,116 | $11.0K |
| Elequin Capital LP | 506 | $5.00K |